Search for Clinical Trial Results
Adenoma - 646 Studies Found
Status | Study |
Recruiting |
Study Name: Suitability of DCE-MRI for Detection of Vascular Changes After VBT Condition: Carcinoma of the Cervix, Carcinoma or Carcinosarcoma of the Uterus Date: 2013-11-11 Interventions: Radiation: Radiotherapy |
Recruiting |
Study Name: Pazopanib vs. Pazopanib Plus Gemcitabine in Patients With Relapsed or Metastatic Uterine Leiomyosarcomas or Uterine Carcinosarcomas: a Multi-center, Randomized Phase-II Clinical Trial of the NOGGO and AGO - PazoDoble - Condition: Relapsed or Metastatic Uterine Leiomyosarcomas or Carcinosarcomas Date: 2014-05-05 Interventions:
|
Completed |
Study Name: Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer Condition:
Date: 2010-11-23 Interventions: Drug: Pazopanib Hydrochloride Given PO Other Names: |
Active, not recruiting |
Study Name: Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer Condition:
Date: 2010-07-22 Interventions:
|
Terminated |
Study Name: Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus Condition:
Date: 2010-02-02 Interventions: Drug: temsirolimus Given IV Other Names: |
Completed |
Study Name: Evaluation of Paclitaxel (Taxol, NSC #673089), Carboplatin (Paraplatin, NSC #241240), and BSI-201 (NSC #746045, IND #71,677) in the Treatment of Advanced, Persistent, or Recurrent Uterine Carcinosarcoma Condition: Uterine Carcinosarcoma Date: 2008-05-28 Interventions:
|
Completed |
Study Name: Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer Condition:
Date: 2005-06-13 Interventions:
|
Completed |
Study Name: Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Cancer Condition:
Date: 2004-01-09 Interventions:
|
Completed |
Study Name: Thalidomide in Treating Patients With Recurrent or Persistent Carcinosarcoma of the Uterus Condition:
Date: 2001-10-11 Interventions:
|
Completed |
Study Name: Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors Condition:
Date: 2008-12-30 Interventions:
|